1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Clinical characteristics of the local treatment cohorts
Carotid Stenting (n = 134) Carotid Endarterectomy (n = 66) Mean age (yr) (SD) 72.2 (8.5) 69 (8.8) Women 28.4 (38/134) 22.7 (15/66) Risk factors Coronary artery disease 45.5 (61/134) 18.2 (12/66) Diabetes 30.6 (40/134) 43.9 (29/66) Hypertension 88.1 (118/134) 68.2 (45/66) Current smoking 32.1 (43/134) 31.8 (21/66) Qualifying event Retinal events 18.7 (25/134) 16.7 (11/66) TIA 32.7 (44/134) 39.4 (26/66) Stroke 29.9 (40/134) 25.7 (17/66) Asymptomatic 18.7 (25/134) 18.2 (12/66)